Cargando…

Projected impact of a multigene pharmacogenetic test to optimize medication prescribing in cardiovascular patients

AIM: To determine the projected impact of a multigene pharmacogenetic (PGx) test on medication prescribing. MATERIALS & METHODS: A retrospective analysis was conducted with 122 cardiac catheterization laboratory patients undergoing angiography for eligibility of potential PGx-guided intervention...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dong, Olivia M, Li, Amy, Suzuki, Oscar, Oni-Orisan, Akinyemi, Gonzalez, Ricardo, Stouffer, George A, Lee, Craig R, Wiltshire, Tim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Future Medicine Ltd 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6367721/ https://www.ncbi.nlm.nih.gov/pubmed/29793377 http://dx.doi.org/10.2217/pgs-2018-0049

Ejemplares similares

QT Interval Dynamics and Cardiovascular Outcomes: A Cohort Study in an Integrated Health Care Delivery System
por: Mantri, Neha, et al.
Publicado: (2021)

Pharmacogenetic Analysis of the Model‐Based Pharmacokinetics of Five Anti‐HIV Drugs: How Does This Influence the Effect of Aging?
por: Chen, Jingxian, et al.
Publicado: (2017)

Antidepressant prescribing in the precision medicine era: a prescriber’s primer on pharmacogenetic tools
por: Bousman, Chad A., et al.
Publicado: (2017)

Development and application of an algorithm for statin-induced myopathy based on electronic health record-derived structured elements
por: Oni-Orisan, Akinyemi, et al.
Publicado: (2023)

Pharmacogenetic actionability and medication prescribing in people with cystic fibrosis
por: Anderson, Justin D., et al.
Publicado: (2023)

Torsade de pointes: A nested case–control study in an integrated healthcare delivery system
por: Mantri, Neha, et al.
Publicado: (2021)

Diversity in Clinical Pharmacology: A Call to Action
por: Brown, Karen, et al.
Publicado: (2023)

Establishment of a Pharmacogenetics Service Focused on Optimizing Existing Pharmacogenetic Testing at a Large Academic Health Center
por: Pasternak, Amy L., et al.
Publicado: (2020)

Projected Prevalence of Actionable Pharmacogenetic Variants and Level A Drugs Prescribed Among US Veterans Health Administration Pharmacy Users
por: Chanfreau-Coffinier, Catherine, et al.
Publicado: (2019)

Modest effect of statins on fasting glucose in a longitudinal electronic health record based cohort
por: Haldar, Tanushree, et al.
Publicado: (2022)

The Role of Pharmacogenetics in Management of Cardiovascular Disease
por: Topic, Elizabeta
Publicado: (2003)

PERSONAL: Feasibility Study Protocol for Placebo-Controlled, Randomized n-of-1 Trials of Tamsulosin for Lower Urinary Tract Symptoms
por: Bauer, Scott R., et al.
Publicado: (2020)

Optimization of Antidepressant use with Pharmacogenetic Strategies
por: Torrellas, Clara, et al.
Publicado: (2017)

Resection of a recurrent cervical internal carotid artery pseudoaneurysm after failed endovascular therapy
por: Nguyen, Ha Son, et al.
Publicado: (2016)

Pharmacogenetics of Risperidone and Cardiovascular Risk in Children and Adolescents
por: Dos Santos-Júnior, Amilton, et al.
Publicado: (2016)

Genetics and pharmacogenetics in the diagnosis and therapy of cardiovascular diseases
por: Krasi, Geraldo, et al.
Publicado: (2019)

The impact of adjusting for baseline in pharmacogenomic genome-wide association studies of quantitative change
por: Oni-Orisan, Akinyemi, et al.
Publicado: (2020)

Primary care and mental health providers’ perceptions of implementation of pharmacogenetics testing for depression prescribing
por: Vest, Bonnie M., et al.
Publicado: (2020)

Pharmacogenetic interventions to improve outcomes in patients with multimorbidity or prescribed polypharmacy: a systematic review
por: O’Shea, Joseph, et al.
Publicado: (2022)

1206. A Quality Improvement Project Utilizing Clinical Decision Support (CDS) to Optimize Outpatient Antibiotic Prescribing
por: Mason, Matt, et al.
Publicado: (2023)

Corrigendum to “Pharmacogenetics of Risperidone and Cardiovascular Risk in Children and Adolescents”
por: Dos Santos-Júnior, Amilton, et al.
Publicado: (2017)

Leveraging innovative technology to generate drug response phenotypes for the advancement of biomarker‐driven precision dosing
por: Oni‐Orisan, Akinyemi, et al.
Publicado: (2021)

Perceptions of Older Men Using a Mobile Health App to Monitor Lower Urinary Tract Symptoms and Tamsulosin Side Effects: Mixed Methods Study
por: Wang, Elizabeth Y, et al.
Publicado: (2021)

Tracking Lower Urinary Tract Symptoms and Tamsulosin Side Effects Among Older Men Using a Mobile App (PERSONAL): Feasibility and Usability Study
por: Lee, Austin W, et al.
Publicado: (2021)

Correction to: Pharmacogenetic interventions to improve outcomes in patients with multimorbidity or prescribed polypharmacy: a systematic review
por: O’Shea, Joseph, et al.
Publicado: (2022)

Ceftazidime resistance in Pseudomonas aeruginosa is multigenic and complex
por: Ramsay, Kay A., et al.
Publicado: (2023)

Pharmacogenetic analyses of variations of measures of cardiovascular risk in Alzheimer's dementia
por: de Oliveira, Fabricio Ferreira, et al.
Publicado: (2019)

Evolution and variation of multigene families
por: Ohta, Tomoko
Publicado: (1980)

Important Pharmacogenetic Information for Drugs Prescribed During the SARS‐CoV‐2 Infection (COVID‐19)
por: Zubiaur, Pablo, et al.
Publicado: (2020)

Pharmacogenetic Associations of MMP9 and MMP12 Variants with Cardiovascular Disease in Patients with Hypertension
por: Tanner, Rikki M., et al.
Publicado: (2011)

Multigene interactions and the prediction of depression in the Wisconsin Longitudinal Study
por: Roetker, Nicholas S, et al.
Publicado: (2012)

An optimized prediction framework to assess the functional impact of pharmacogenetic variants
por: Zhou, Yitian, et al.
Publicado: (2018)

Pharmacogenetic Testing: A Tool for Personalized Drug Therapy Optimization
por: Malsagova, Kristina A., et al.
Publicado: (2020)

Use of Pharmacogenetics to Optimize Immunosuppressant Therapy in Kidney-Transplanted Patients
por: Urzì Brancati, Valentina, et al.
Publicado: (2022)

Pharmacogenetic Guidelines for Psychotropic Drugs: Optimizing Prescriptions in Clinical Practice
por: Baldacci, Antoine, et al.
Publicado: (2023)

Pharmacogenetics of hepatocellular carcinoma and cholangiocarcinoma
por: Alonso-Peña, Marta, et al.
Publicado: (2019)

Sequence2Script: A Web-Based Tool for Translation of Pharmacogenetic Data Into Evidence-Based Prescribing Recommendations
por: Bousman, Chad A., et al.
Publicado: (2021)

Patients with geographic barriers to health care access are prescribed a higher proportion of drugs with pharmacogenetic testing guidelines
por: Dalton, Rachel, et al.
Publicado: (2021)

Mental Health Prescribers’ Perceptions on the Use of Pharmacogenetic Testing in the Management of Depression in the Middle East and North Africa Region
por: Aboelbaha, Shimaa, et al.
Publicado: (2023)

Pharmacogenetic Association of NOS3 Variants with Cardiovascular Disease in Patients with Hypertension: The GenHAT Study
por: Zhang, Xue, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_gd6c0dfd7tjc2fug4rr7mkqrh0